These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24238351)

  • 1. Upscheduling of hydrocodone: convenience and access vs patient safety measures.
    Schatman ME; Darnall BD
    Pain Med; 2013 Nov; 14(11):1627. PubMed ID: 24238351
    [No Abstract]   [Full Text] [Related]  

  • 2. The downside of upscheduling.
    Gudin J; Lee AJ
    Pain Med; 2013 Nov; 14(11):1628-9. PubMed ID: 24238353
    [No Abstract]   [Full Text] [Related]  

  • 3. Better late than never: time to up-schedule hydrocodone combination products.
    Kolodny A
    Pain Med; 2013 Nov; 14(11):1627-8. PubMed ID: 24238352
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA to propose hydrocodone reclassification.
    J Calif Dent Assoc; 2014 Jan; 42(1):10. PubMed ID: 25080676
    [No Abstract]   [Full Text] [Related]  

  • 5. Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone users.
    Murimi IB; Chang HY; Bicket M; Jones CM; Alexander GC
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):70-79. PubMed ID: 30187574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrocodone prescriptions.
    Liewehr FR
    J Am Dent Assoc; 2013 Aug; 144(8):876. PubMed ID: 23904570
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA advisory panel assesses hydrocodone prescription writing: every dentist's responsibility.
    Curro FA
    J Am Dent Assoc; 2013 May; 144(5):462-4. PubMed ID: 23633687
    [No Abstract]   [Full Text] [Related]  

  • 8. Food and Drug Administration upscheduling of hydrocodone and the effects on nurse practitioner pain management practices.
    Mack R
    J Am Assoc Nurse Pract; 2018 Jun; 30(6):312-319. PubMed ID: 29878963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Among disparate views, scales tipped by the ethics of system integrity.
    Schatman ME; Darnall BD
    Pain Med; 2013 Nov; 14(11):1629-30. PubMed ID: 24238354
    [No Abstract]   [Full Text] [Related]  

  • 10. Author's response.
    Curro FA
    J Am Dent Assoc; 2013 Aug; 144(8):876-7. PubMed ID: 23904571
    [No Abstract]   [Full Text] [Related]  

  • 11. US bill would force FDA to withdraw approval of new pain drug Zohydro.
    McCarthy M
    BMJ; 2014 Mar; 348():g2195. PubMed ID: 24637611
    [No Abstract]   [Full Text] [Related]  

  • 12. DEA reschedules hydrocodone combination products.
    Pergolizzi JV
    Pain Pract; 2015 Feb; 15(2):95-7. PubMed ID: 25639283
    [No Abstract]   [Full Text] [Related]  

  • 13. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
    Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
    J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA committee: More restrictions needed on hydrocodone combination products.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):862. PubMed ID: 23462764
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of hydrocodone reclassification on analgesic prescribing in the Veterans Health Administration.
    Steckler TJ; Mosher HJ; Desloover-Koch Y; Lund BC
    Am J Health Syst Pharm; 2019 May; 76(Supplement_2):S61-S67. PubMed ID: 30873558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.
    Hall PB
    W V Med J; 2014; 110(6):6-10. PubMed ID: 25651658
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA panel recommends tighter rules for prescribing opioids.
    McCarthy M
    BMJ; 2013 Feb; 346():f1012. PubMed ID: 23412738
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent developments toward the safer use of opioids, with a focus on hydrocodone.
    Covvey JR
    Res Social Adm Pharm; 2015; 11(6):901-8. PubMed ID: 25769501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA advisers support rescheduling of hydrocodone products.
    Traynor K
    Am J Health Syst Pharm; 2013 Mar; 70(5):383-4. PubMed ID: 23413158
    [No Abstract]   [Full Text] [Related]  

  • 20. REMS; red tape, or a remedy for opioid abuse?
    Porada S
    J Fam Pract; 2011 Sep; 60(9 Suppl):S55-62. PubMed ID: 22442761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.